HC Wainwright & Co. Maintains Buy on NovaBridge Biosciences, Raises Price Target to $9
NovaBridge Biosciences +2.36%
NovaBridge Biosciences NBP | 2.60 | +2.36% |
HC Wainwright & Co. analyst Andres Y. Maldonado maintains NovaBridge Biosciences (NASDAQ:
NBP) with a Buy and raises the price target from $7 to $9.
